Theratechnologies Provides Update on EGRIFTA SV® Supply
Portfolio Pulse from
Theratechnologies Inc. announced a shortage of EGRIFTA SV® due to a voluntary shutdown of its manufacturing facility in 2024. This will lead to stockouts in several US pharmacies by mid-January 2025.
January 09, 2025 | 10:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Theratechnologies Inc. announced a shortage of EGRIFTA SV® due to a manufacturing shutdown, leading to stockouts in US pharmacies by mid-January 2025.
The announcement of a shortage of EGRIFTA SV® due to a manufacturing shutdown is likely to negatively impact Theratechnologies' stock price in the short term. The shortage could affect sales and revenue, leading to investor concerns.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100